Max-Fernand Robba

Title: Max-Fernand Robba: Innovator in Pharmaceutical Chemistry

Introduction

Max-Fernand Robba is a notable inventor based in Caen, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that influence cerebral histamine release. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Max-Fernand Robba holds 2 patents that focus on 4-(4-imidazolyl) piperidines. These compounds are characterized by their complex chemical structures, which include various substituents that enhance their therapeutic potential. The patents detail the preparation and application of these compounds, which are designed to control the release of cerebral histamine and improve the rate of renewal of this important neurotransmitter.

Career Highlights

Throughout his career, Robba has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Société Civile Bioprojet. His work in these institutions has allowed him to collaborate with leading experts in the field, furthering his research and innovation in pharmaceutical applications.

Collaborations

Some of his notable coworkers include Jean-Michel Arrang and Jean-Charles M. Lancelot. Their collaborative efforts have contributed to the advancement of research in the area of cerebral histamine and its implications for health.

Conclusion

Max-Fernand Robba's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for future innovations in medical science.